logo-loader
Feature

Lumos Diagnostics builds US commercial momentum as FebriDx rollout accelerates

Lumos Diagnostics Holdings Ltd (ASX:LDX, OTC:LDXHF) is entering a key commercial phase in the...

6 days, 13 hours ago
Deep Dive

Anteris Technologies' transcatheter heart valve continues to demonstrate its...

Anteris Technologies Ltd (ASX:AVR) (OTCMKTS:AMEUF) (FRA:DDF) is aiming to revolutionise the...

2 weeks, 4 days ago
Insight

Inside biotech: Personalised mRNA cancer vaccine cuts melanoma recurrence...

A personalised mRNA cancer vaccine jointly developed by Moderna Inc (NASDAQ:MRNA, XETRA:0QF) and...

4 weeks ago

XanaMIA results: What's next for Actinogen Medical?

Actinogen Medical Ltd CEO Dr Steven Gourlay talked with Proactive about the topline results from the company's XanaMIA clinical trial, which evaluated its investigational Alzheimer's disease treatment Xanamem. The study revealed encouraging signs of disease slowing in patients aged...

9 hours, 42 minutes ago

Join Proactive

Get ahead of the curve